Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. Shares Outstanding 2019–2025
Allogene Therapeutics Inc. annual/quarterly shares outstanding history and growth rate from 2019 to 2025. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Allogene Therapeutics Inc. shares outstanding for the quarter ending September 30, 2025 was 0.22 B shs, a 6.14% increase year-over-year.
- Allogene Therapeutics Inc. annual shares outstanding for 2025 was 0.22 B shs, a 13.25% increase from 2024.
- Allogene Therapeutics Inc. annual shares outstanding for 2024 was 0.19 B shs, a 24.14% increase from 2023.
- Allogene Therapeutics Inc. annual shares outstanding for 2023 was 0.16 B shs, a 9.63% increase from 2022.
- Allogene Therapeutics Inc. annual shares outstanding for 2022 was 0.14 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Allogene Therapeutics Inc. Shares Outstanding — FAQ
Allogene Therapeutics Inc. (ALLO) shares outstanding over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Allogene Therapeutics Inc.'s shares outstanding?
Allogene Therapeutics Inc. (ALLO) reported shares outstanding of 0.22B shares for fiscal 2025.
Where can I see ALLO's shares outstanding history?
The chart and table above show Allogene Therapeutics Inc.'s shares outstanding by year and by quarter, including the growth rate.